TOP-V122
/ Topadur Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 14, 2025
The combined treatment with TOP-V122, a dual-acting NO-releasing PDE-5 inhibitor, and ionizing irradiation as a novel therapeutical strategy for colorectal carcinoma.
(PubMed, Radiother Oncol)
- "The PDE-5 inhibitor TOP-V122 represents a novel therapeutic option for colorectal cancer alone and in combination with radiotherapy."
Journal • Colon Cancer • Colorectal Cancer • Oncology • Solid Tumor • CDKN1A
1 to 1
Of
1
Go to page
1